Cell-based Therapies: Current Issues and Future Directions

Veterinary Clinics of North America - Equine Practice

Volumn 27, Issue 2, 2011, Pages 393-399

  Stewart, Matthew C ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Biologics; Clinical trials; Efficacy; Mesenchymal stem cells

Indexed keywords

ANIMAL; ANIMAL DISEASE; HORSE; HORSE DISEASE; PHYSIOLOGY; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; VETERINARY MEDICINE;

ANIMALS; HORSE DISEASES; HORSES; STEM CELL TRANSPLANTATION; STEM CELLS; TREATMENT OUTCOME; VETERINARY MEDICINE;

ANIMALIA; EQUIDAE;

EID: 80052084395     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2011.07.001     Document Type: Review

References (41)

1. Sutter W.W. Therapy for tendon and ligament injuries. Clin Tech Equine Pract 2007, 6:198-208.
2. Mochizuki T., Muneta T., Sakaguchi Y., et al. Higher chondrogenic potential of fibrous synovium- and adipose synovium-derived cells compared with subcutaneous fat-derived cells. Arthritis Rheum 2006, 54:843-853.
3. English A., Jones E.A., Corscadden D., et al. A comparative assessment of cartilage and joint fat pad as a potential source of cells for autologous therapy development in knee osteoarthritis. Rheumatology 2007, 46:1676-1683.
4. Sakaguchi Y., Sekiya I., Yagishita K., et al. Comparison of human stem cells derived from various mesenchymal tissues. Arthritis Rheum 2005, 52:2521-2529.
5. Yoshimura H., Muneta T., Nimura A., et al. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res 2007, 327:449-462.
6. De Schauwer C., Meyer E., Van de Walle G.R., et al. Markers of stemness in equine mesenchymal stem cells: a plea for uniformity. Theriogenology 2010, 75:1431-1443.
7. Tse W.T., Pendleton J.D., Beyer W.M., et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003, 75:389-397.
8. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
9. Guest D.J., Smith M.R., Allen W.R. Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon. Equine Vet J 2010, 42:636-642.
10. Watts A.E., Yeager A.E., Kopyov O.V., et al. Fetal derived embryonic-like stem cells improve healing in a large animal flexor tendonitis model. Stem Cell Res Ther 2011, 2:4.
11. Im G., Shin Y., Lee K. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells?. Osteoarthritis Cartilage 2005, 13:845-853.
12. Rebelatto C.K., Aguiar A.M., Moretao M.P., et al. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med 2008, 233:901-913.
13. Danišovic L., Varga I., Polak S., et al. Comparison of in vitro chondrogenic potential of human mesenchymal stem cells derived from bone marrow and adipose tissue. Gen Physiol Biophys 2009, 28:56-62.
14. Jäger M., Herten M., Fochtmann U., et al. Bridging the gap: bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects. J Orthop Res 2010, 29:173-180.
15. Hernigou P., Poignard A., Beaujean F., et al. Percutaneous autologous bone-marrow grafting for nonunions: influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 2005, 87:1430-1437.
16. Vadalá G., Di Martino A., Tirindelli M.C., et al. Use of autologous bone marrow cells concentrate enriched with platelet-rich fibrin on corticocancellous bone allograft for posterolateral multilevel cervical fusion. J Tissue Eng Regen Med 2008, 2:515-520.
17. Crovace A., Lacitignola L., Rossi G., et al. Histological and immunohistochemical evaluation of autologous cultured bone marrow mesenchymal stem cells and bone marrow mononucleated cells in collagenase-induced tendinitis of equine superficial digital flexor tendon. Vet Med Int 2010, 2010:250978.
18. Fortier L.A., Potter H.G., Rickey E.J., et al. Concentrated bone marrow aspirate improves full-thickness cartilage repair compared with microfracture in the equine model. J Bone Joint Surg Am 2010, 92:1927-1937.
19. Nixon A.J., Dahlgren L.A., Haupt J.L., et al. Effect of adipose-derived nucleated cell fractions on tendon repair in horses with collagenase-induced tendinitis. Am J Vet Res 2008, 69:928-937.
20. Waselau M., Sutter W.W., Genovese R.L., et al. Intralesional injection of platelet-rich plasma followed by controlled exercise for treatment of midbody suspensory ligament desmitis in Standardbred racehorses. J Am Vet Med Assoc 2008, 232:1515-1520.
21. Bosch G., van Schie H.T., de Groot M.W., et al. Effects of platelet-rich plasma on the quality of repair of mechanically induced core lesions in equine superficial digital flexor tendons: a placebo-controlled experimental study. J Orthop Res 2010, 28:211-217.
22. Frisbie D.D., Kawcak C.E., Werpy N.M., et al. Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis. Am J Vet Res 2007, 68:290-296.
23. Ozaki Y., Nishimura M., Sekiya K., et al. Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells. Stem Cell Dev 2007, 16:119-129.
24. Ponte A.L., Marais E., Gallay N., et al. Mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007, 25:1737-1745.
25. Bhaktaa S., Hong P., Koc O., et al. The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation. Cardiovasc Revasc Med 2006, 7:19-24.
26. Ji J.F., He B.P., Dheen S.T., et al. Interactions of chemokines and chemokine receptors mediate the migration of stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 2004, 22:415-427.
27. Le Blanc K., Frassoni F., Ball L., et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008, 371:1579-1586.
28. Freedman M.S., Bar-Or A., Atkins H.L., et al. The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group. Mult Scler 2010, 16:503-510.
29. Hoogduijn M.J., Popp F.C., Grohnert A., et al. Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT). Transplantation 2010, 90:124-126.
30. Shi Y., Hu G., Su J., et al. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res 2010, 20:510-518.
31. Djouad F., Bouffi C., Ghannam S., et al. Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases. Nat Rev Rheumatol 2009, 5:392-399.
32. Horwitz E.M., Prockop D.J., Gordon P.L., et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 2001, 97:1227-1231.
33. Wilke M.M., Nydam D.V., Nixon A.J. Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. J Orthop Res 2007, 25:913-925.
34. Frisbie D.D., Kisiday J.D., Kawcak C.E., et al. Evaluation of adipose derived stromal vascular fraction or bone marrow derived mesenchymal stem cells for treatment of osteoarthritis. J Orthop Res 2009, 27:1675-1680.
35. Crovace A., Lacitignola L., De Siena R., et al. Cell therapy for tendon repair in horses: an experimental study. Vet Res Commun 2007, 31(Suppl 1):281-283.
36. Schnabel L.V., Lynch M.E., van der Meulen M.C., et al. Mesenchymal stem cells and insulin-like growth factor-I gene-enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficialis tendons. J Orthop Res 2009, 27:1392-1398.
37. Carvalho A., Alves A., de Oliveira P., et al. Use of adipose tissue-derived mesenchymal stem cells for experimental tendinitis therapy in equines. J Equine Vet Sci 2011, 31:26-34.
38. Ferris D.J., Frisbie D.D., Kisiday J.D., et al. Clinical follow-up of horses treated with bone marrow derived mesenchymal stem cells for musculoskeletal lesions. Proc AAEP Ann Conv 2009, 55:59.
39. Govender S., Csimma C., Genant H.K., et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002, 84:2123-2134.
40. Friedlaender G.E., Perry C.R., Cole J.D., et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 2001, 83(Suppl 1):S151-S158.
41. Burkus J.K., Gornet M.F., Dickman C.A., et al. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 2002, 15:337-349.